Exploration shows effective reversal of cancer cell reprogramming using hypoxia-triggered dichloroacetate delivery, suggesting therapeutic potential.
Dichloroacetate (DCA) is a known inhibitor of pyruvate dehydrogenase kinase, which is part of the key enzyme complex in metabolic reprogramming of cancer cells. In this work, we structurally modified...
No takes yet. Share an insight, caveat, or question.
sun et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: